Sensorcaine(r) (bupivacaine Hci And Epinephrine)
Generic Name: sensorcaine(r) (bupivacaine hci and epinephrine)
Brand Names:
Sensorcaine(r) (bupivacaine Hci And Epinephrine)
DESCRIPTION Sensorcaine ® (bupivacaine HCl) injections are sterile isotonic solutions that contain a local anesthetic agent with and without epinephrine (as bitartrate) 1:200,000 and are administered parenterally by injection. See INDICATIONS & USAGE for specific uses. Solutions of bupivacaine HCl may be autoclaved if they do not contain epinephrine.
Overview
DESCRIPTION Sensorcaine ® (bupivacaine HCl) injections are sterile isotonic solutions that contain a local anesthetic agent with and without epinephrine (as bitartrate) 1:200,000 and are administered parenterally by injection. See INDICATIONS & USAGE for specific uses. Solutions of bupivacaine HCl may be autoclaved if they do not contain epinephrine.
Uses
INDICATIONS & USAGE Sensorcaine (bupivacaine HCl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see WARNINGS ). Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine HCl in these patients. Sensorcaine is not recommended for intravenous regional anesthesia (Bier Block) (see WARNINGS ).
Dosage
DOSAGE & ADMINISTRATION The dose of any local anesthetic administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. The smallest dose and concentration required to produce the desired result should be administered. Dosages of Sensorcaine should be reduced for elderly and/or debilitated patients and patients with cardiac and/or liver disease. The rapid injection of a large volume of local anesthetic solution should be avoided and fractional (incremental) doses should be used when feasible.
Side Effects
ADVERSE REACTIONS Reactions to Sensorcaine (bupivacaine HCl) are characteristic of those associated with other amide- type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, unintentional intravascular injection, or slow metabolic degradation. The most commonly encountered acute adverse experiences which demand immediate counter-measures are related to the central nervous system and the cardiovascular system. These adverse experiences are generally dose related and due to high plasma levels which may result from overdosage, rapid absorption from the injection site, diminished tolerance, or from unintentional intravascular injection of the local anesthetic solution.
Warnings
BOXED WARNING BOX WARNING WARNINGS Methemoglobinemia: Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended. CONTRAINDICATIONS Sensorcaine (bupivacaine HCl) is contraindicated in obstetrical paracervical block anesthesia. Its use in this technique has resulted in fetal bradycardia and death. Sensorcaine is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of bupivacaine solutions.
Storage
HOW SUPPLIED SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE INJECTION, USP) WITH EPINEPHRINE is supplied in the following dosage forms. NDC 51662-1397-1 SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE INJECTION, USP) WITH EPINEPHRINE 1:200,000 (AS BITARTRATE) 0.25% 125mg per 50mL (2.5mg per mL) 50mL VIAL NDC 51662-1397-2 Pouch Containing 1 Vial of - SENSORCAINE® W/ EPI 1:200,000 (AS BITARTRATE) 0...
Frequently Asked Questions
What is Sensorcaine(r) (bupivacaine Hci And Epinephrine) used for?▼
INDICATIONS & USAGE Sensorcaine (bupivacaine HCl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see WARNINGS ). Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine HCl in these patients. Sensorcaine is not recommended for intravenous regional anesthesia (Bier Block) (see WARNINGS ).
What are the side effects of Sensorcaine(r) (bupivacaine Hci And Epinephrine)?▼
ADVERSE REACTIONS Reactions to Sensorcaine (bupivacaine HCl) are characteristic of those associated with other amide- type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, unintentional intravascular injection, or slow metabolic degradation. The most commonly encountered acute adverse experiences which demand immediate counter-measures are related to the central nervous system and the cardiovascular system. These adverse experiences are generally dose related and due to high plasma levels which may result from overdosage, rapid absorption from the injection site, diminished tolerance, or from unintentional intravascular injection of the local anesthetic solution.
What are the important warnings for Sensorcaine(r) (bupivacaine Hci And Epinephrine)?▼
BOXED WARNING BOX WARNING WARNINGS Methemoglobinemia: Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended. CONTRAINDICATIONS Sensorcaine (bupivacaine HCl) is contraindicated in obstetrical paracervical block anesthesia. Its use in this technique has resulted in fetal bradycardia and death. Sensorcaine is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of bupivacaine solutions.
Related Medications
Acetaminophen, Dextromethorphan Hydrobromide, And Triprolidine Hydrochloride
acetaminophen, dextromethorphan hydrobromide, and triprolidine hydrochloride
Active ingredients (in each 20 mL) Purposes Acetaminophen 650 mg Pain reliever/fever reducer Dextromethorphan HBr 20 mg Cough suppressant Triprolidine HCl 2.5 mg Antihistamine
Ascorbicum Acidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, Dhea (dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Alpha-lipoicum Acidum, Citricum Acidum, Fumaricum Acidum, Nadidum, Pantothenic Acid, Acetaldehyde, Insulinum (suis), Insulinum (human), Hepar Suis, Pancreas Suis, Phloridzinum, Alloxanum, Berberis Vulgaris, Carcinosin, Lycopodium Clavatum, Momordica Balsamina, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum,
ascorbicum acidum, pyridoxinum hydrochloricum, riboflavinum, sarcolacticum acidum, thiaminum hydrochloricum, dhea (dehydroepiandrosterone), adenosinum triphosphoricum dinatrum, alpha-lipoicum acidum, citricum acidum, fumaricum acidum, nadidum, pantothenic acid, acetaldehyde, insulinum (suis), insulinum (human), hepar suis, pancreas suis, phloridzinum, alloxanum, berberis vulgaris, carcinosin, lycopodium clavatum, momordica balsamina, phosphoricum acidum, phosphorus, syzygium jambolanum,
Calculi Dissolution Agent [EPC]
PURPOSE: Acetaldehyde - Thirst, Adenosinum Triphosphoricum Dinatrum – Dry Mouth, Alloxanum – Sugar Cravings, Alpha-Lipoicum Acidum – Night Sweats, Ascorbic Acid – Sugar Cravings, Barium Oxalsuccinicum – Sugar Cravings, Berberis Vulgaris - Thirst, Carcinosin – Carbohydrate Cravings, Citricum Acidum – Dry Mouth, DHEA (Dehydroepiandrosterone) – Night Sweats, Fumaricum Acidum – Sugar Cravings, Gaertner Bacillus (Bach) – Night Sweats, Gymnema Sylvestre - Thirst, Hepar Suis – Dry Mouth, Insulinum – Ni
Apis Mellifera, Arnica Montana, Blatta Orientalis, Dieffenbachia Seguine, Cimex Lectularius, Culex Pipiens, Formica Rufa, Hypericum Perforatum, Latrodectus Mactans, Ledum Palustre Twig, Loxosceles Reclusa, Pediculus Humanus Var. Capitis, Pulex Irritans, Delphinium Staphisagria Seed, Vespa Crabro.
apis mellifera, arnica montana, blatta orientalis, dieffenbachia seguine, cimex lectularius, culex pipiens, formica rufa, hypericum perforatum, latrodectus mactans, ledum palustre twig, loxosceles reclusa, pediculus humanus var. capitis, pulex irritans, delphinium staphisagria seed, vespa crabro.
Standardized Insect Venom Allergenic Extract [EPC]
USES: Temporarily relieves cough, itching &/or other symptoms related to insect bites & stings.**
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.